Whole Exome Sequencing (WES) is a genomic technique for sequencing all the protein-coding regions of genes in a genome. These regions are known as exons and represent about 1-2% of the human genome. Despite their small proportion of the genome, exons harbor the majority of known disease-related genetic variants, making WES a powerful tool for identifying mutations associated with cancer.